FAISAL BUKHARI: Open Payments
NPI 1376545509 · SULLIVAN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$275 in 14 payments from 8 companies in 2025. Trend: 2023 $781 · 2024 $522 · 2025 $275
Food & beverage: $275
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $90 |
| Lilly USA, LLC | 2 | $48 |
| Abbott Laboratories | 2 | $39 |
| PFIZER INC. | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: REXULTI, MOUNJARO, FREESTYLE LIBRE 3, ELIQUIS, INGREZZA, CREON, BREZTRI.
Industry payments across IL — which companies pay providers there.
